Vyome Biosciences is an innovation driven company, with a vision to develop novel treatments for antibiotics-resistant acne and other opportunist pathogens through a unique pipeline of drugs that retard antimicrobial resistance development
Vyome Biosciences Administers First In-human Dose of VB 1953View More
Read More to know about Vyome's Vision and PlansView More
Read More to know about Vyome's innovative and patented technology platforms for partnering opportunitiesView More
Read More to know about Vyome's pipeline of novel products developed using breakthrough technology platforms, and available for partneringView More
Team with expertise, demonstrated capability and track record of launching 50+ drugsView More
Read More to discover partnership opportunities with Vyome on technology platforms and productsView More
Copyright © 2015 Vyome Biosciences. All rights reserved.